---
title: "688046.SH (688046.SH) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/688046.SH/news.md"
symbol: "688046.SH"
name: "688046.SH"
parent: "https://longbridge.com/en/quote/688046.SH.md"
datetime: "2026-03-11T14:56:29.481Z"
locales:
  - [en](https://longbridge.com/en/quote/688046.SH/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/688046.SH/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/688046.SH/news.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/quote/688046.SH/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/688046.SH/news.md)


# 688046.SH (688046.SH) — Related News

### [The US and Taiwan sign a trade agreement to promote economic growth, memory prices soar, and Hancoin's new drug receives FDA certification, showcasing potential](https://longbridge.com/en/news/275854342.md)
*2026-02-13T05:40:03.000Z*
> The Taiwan-U.S. signed a reciprocal trade agreement, reducing the import tariff on beef to 0% and gradually lowering tar

### [GEMPHARMATECH: The invested company plans to repurchase shares worth 10 million yuan, involving related party transactions](https://longbridge.com/en/news/271757812.md)
*2026-01-07T08:24:24.000Z*
> GEMPHARMATECH announced that its affiliated company Jiangxi Zhonghong Investment plans to repurchase shares worth 10 mil

### [GEMPHARMATECH: After two rounds of repurchase, it plans to implement differentiated dividends with a proposed cash distribution of 12.2691 million yuan](https://longbridge.com/en/news/265702755.md)
*2025-11-13T11:09:58.000Z*
> GEMPHARMATECH announced that the company has completed two phases of its repurchase plan, with a total of 3.07 million s

### [GEMPHARMATECH 2025 Q3 Institutional Positioning Indicator](https://longbridge.com/en/news/262328385.md)
*2025-10-23T01:09:12.000Z*
> On October 23, 2025, GEMPHARMATECH released its third-quarter report. As of October 22, a total of 10 institutional inve

### [GEMPHARMATECH: The net profit for the third quarter of 2025 is 110 million yuan](https://longbridge.com/en/news/262315725.md)
*2025-10-22T23:10:29.000Z*
> On October 23, 2025, GEMPHARMATECH released its third-quarter report, which showed that the company's total operating re

### [GEMPHARMATECH released its performance for the first three quarters, with a net profit attributable to the parent company of 110 million yuan, a year-on-year increase of 11.9%](https://longbridge.com/en/news/262206753.md)
*2025-10-22T09:55:02.000Z*
> According to the Zhitong Finance APP, GEMPHARMATECH disclosed its third-quarter report for 2025. The company achieved re